India to Trinidad And Tobago Pharmaceutical Export (2026) — $6.4M, 88 Suppliers | TransData Nexus

India to Trinidad And Tobago Pharmaceutical Export (2026) — $6.4M, 88 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Trinidad And Tobago

#	Formulation	Value	Share
1	Flamar Mx Tablet, Pack of 10x10s (each Film Coated Tablet Contains Paracetamol…	$353.4K	5.5%
2	Asthalin Inhaler Cfc Free 200md (salbutamol Sulphate) (1x200 Md)	$196.0K	3.0%
3	Alprostadil Injection USP (prostasol) 0.500 Mg/ml,1ml Vial, 1 Vial Per Box (qty…	$180.9K	2.8%
4	Sherpen 1000mg	$158.4K	2.5%
5	Norethisterone Enanthate and Estradiol Valerate Injection 50 MG + 5 Mg/ml, 1 Ml…	$154.3K	2.4%
6	Enhancin Injection 1.2 G 1's Contains Amoxy+clav Potas Com Pack : 1 Vial Batch…	$136.4K	2.1%
7	Galantamine Hydrobromide Er Capsule 8mg	$117.7K	1.8%
8	(teevir) Tenofovir Disoproxil Fumarate 300mg + Efavirenz 600mg + Emtricitabine…	$114.5K	1.8%
9	Candid B Cream 15gm	$110.7K	1.7%
10	Birato 250mg (1x120s) Anthony-tt	$104.7K	1.6%
11	Sodium Chloride Intravenous Infusion Bp(0.9% W/v) 500ml Bag (ns)	$97.4K	1.5%
12	Harmless Medicines for Human Consumptionas Per Inv Batch No:-bh5001 to Bh5005 (…	$95.0K	1.5%
13	Versavo 400mg/16ml(1 S)(qty:100 Vials)	$88.8K	1.4%
14	Harmless Medicines for Human Consumptionas Per Inv Batch No:sr5011 to Sr5014 (5…	$79.3K	1.2%
15	Labetalol Hcl Injection USP (labesol) 5mg/ml, 20ml Vial, 1 Vial Per Box (qty: 9…	$78.9K	1.2%

India exports 20+ pharmaceutical formulations to Trinidad And Tobago with a combined trade value of $6.4M. Key products include Meropenem ($158K), Tenofovir ($114K), Sodium ($97K), Hydrocortisone ($77K), Esomeprazole ($69K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,314 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Trinidad And Tobago Trade Routes

1Meropenem$158K

2Tenofovir$114K

3Sodium$97K

4Hydrocortisone$77K

5Esomeprazole$69K

These are the top pharmaceutical products exported from India to Trinidad And Tobago, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Trinidad And Tobago buyers, regulatory requirements, and logistics for that specific product corridor. Products include — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Trinidad And Tobago

1Glenmark Pharmaceuticals Limited

$656K

2Indoco Remedies Limited

$514K

3Msn Laboratories Private Limited

$448K

4Cipla Limited

$426K

Port Analysis — India to Trinidad And Tobago Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)24.8%

SAHAR AIR CARGO ACC (INBOM4)35.9%

HYDERABAD ACC (INHYD4)2.7%

AHEMDABAD ICD (INSBI6)0.8%

DELHI AIR CARGO ACC (INDEL4)4.3%

Trinidad And Tobago Import Ports

PORT OF SPAIN, PIARC57.8%

Port of Spain24.0%

Point Lisas9.4%

Tobago0.5%

PEORIA0.8%

Trade Statistics

Total Value$6.4M

Shipments1,314

Indian Exporters88

Trinidad And Tobago Buyers81

Avg Shipment$5K

Products935

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–Trinidad And Tobago Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Trinidad and Tobago has experienced significant growth over the past decade. In 2024, India's pharmaceutical exports to Trinidad and Tobago reached approximately $23.31 million, marking a substantial increase from previous years. This upward trajectory underscores the strengthening economic ties and the growing demand for Indian pharmaceutical products in the Caribbean market.

Key milestones in this bilateral trade include the establishment of direct shipping routes and the participation of Indian pharmaceutical companies in regional trade fairs in Trinidad and Tobago. These initiatives have facilitated better market penetration and enhanced visibility for Indian exporters. The consistent growth reflects the strategic importance of this trade corridor for both nations, with India leveraging its manufacturing capabilities and Trinidad and Tobago serving as a gateway to the Caribbean.

2India's Market Position

India holds a dominant position in Trinidad and Tobago's pharmaceutical import landscape. In 2024, pharmaceutical products accounted for $23.31 million of India's total exports to Trinidad and Tobago, highlighting the sector's significance in bilateral trade. This substantial share indicates India's strategic importance as a supplier of high-quality, cost-effective pharmaceutical formulations to the Caribbean market.

Trinidad And Tobago Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Trinidad and Tobago must adhere to the guidelines set by the Chemistry, Food and Drugs Division (CFDD) of the Ministry of Health. The registration process involves submitting a Drug Submission Form, which includes detailed information such as the drug's description, proposed name, ingredients, route of administration, dosage, and known contraindications and side effects. This comprehensive dossier ensures that the product meets the safety, efficacy, and quality standards required by Trinidad and Tobago's regulatory authorities.

The CFDD evaluates the submitted dossiers to determine compliance with the Food and Drugs Act and Regulations. Upon approval, the product is registered, allowing for its importation and sale within the country. This rigorous process underscores the commitment to maintaining high standards in pharmaceutical imports, ensuring that only safe and effective medications reach the Trinidad and Tobago market.

2GMP & Facility Requirements

Trinidad and Tobago mandates that pharmaceutical products imported into the country be manufactured in facilities adhering to Good Manufacturing Practice (GMP) standards. The CFDD conducts inspections to verify compliance with these standards, ensuring that manufacturing processes meet the required quality benchmarks. While the CFDD does not explicitly recognize WHO-GMP certification, adherence to internationally recognized GMP standards is essential for product registration and importation. This inspection process is crucial for maintaining the integrity and safety of pharmaceutical products available in the Trinidad and Tobago market.

3Import Documentation

Importing pharmaceutical products into Trinidad and Tobago requires specific documentation to ensure compliance with regulatory standards. Key documents include the Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and evidence of GMP compliance. These documents provide assurance of the product's quality, safety, and efficacy. Additionally, importers must adhere to customs procedures, which involve declaring the goods, paying applicable duties, and ensuring that all documentation is accurate and complete. The Customs and Excise Division oversees these procedures, facilitating the smooth importation of pharmaceutical products into the country. (customs.gov.tt)

EXPORT_TRENDS

TransData Nexus Research · Trinidad And Tobago regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Trinidad And Tobago

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

India's pharmaceutical exports to Trinidad and Tobago are predominantly composed of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. These products align with Trinidad and Tobago's healthcare needs, particularly in managing chronic diseases such as diabetes, hypertension, and cardiovascular conditions. The demand for these medications is driven by the prevalence of lifestyle-related diseases in the Caribbean nation, necessitating a steady supply of effective pharmaceutical products.

2Emerging Opportunities

The Caribbean region, including Trinidad and Tobago, presents emerging opportunities for Indian pharmaceutical exporters, especially in the areas of biosimilars and generic medications. As patents for several high-cost drugs expire, there is an increasing demand for affordable alternatives. Indian companies, with their expertise in generic drug manufacturing, are well-positioned to meet this demand, offering cost-effective solutions to the Trinidad and Tobago market. Additionally, the expansion of healthcare infrastructure and government initiatives to improve healthcare access further enhance the prospects for Indian pharmaceutical exports in the region.

3Demand Drivers

Trinidad and Tobago's disease burden, characterized by a high prevalence of chronic conditions such as diabetes, hypertension, and heart disease, significantly drives the demand for pharmaceutical imports. The aging population and increasing healthcare spending trends further contribute to this demand, creating a robust market for pharmaceutical products. Indian pharmaceutical exporters can capitalize on these factors by providing a diverse range of medications tailored to the specific health challenges faced by the Trinidad and Tobago population.

EXPORT_POLICY

TransData Nexus Research · DGFT trade data analysisMar 2026

Trade Policy & Tariff Intelligence — India and Trinidad And Tobago

Tariff structure, trade agreements, IP and patent landscape

1Tariff & Duty Structure

Trinidad and Tobago's tariff and duty structure for pharmaceutical imports is designed to regulate the entry of foreign products and protect domestic industries. While specific tariff rates for pharmaceutical formulations are not publicly disclosed, importers are required to pay applicable duties and taxes upon entry. The Customs and Excise Division oversees the assessment and collection of these duties, ensuring compliance with national trade policies. Importers should consult the latest customs regulations and duty schedules to determine the exact costs associated with importing pharmaceutical products into Trinidad and Tobago. (customs.gov.tt)

2Trade Agreements

Trinidad and Tobago is a member of the Caribbean Community (CARICOM), which facilitates preferential trade agreements among member states. These agreements aim to promote intra-regional trade and may offer benefits such as reduced tariffs and streamlined customs procedures for pharmaceutical imports. However, there is no specific Free Trade Agreement (FTA) between India and Trinidad and Tobago. Indian pharmaceutical exporters should stay informed about regional trade agreements and their implications to optimize market access and competitiveness in the Trinidad and Tobago market.

3IP & Patent Landscape

Trinidad and Tobago's intellectual property (IP) and patent landscape is governed by the Food and Drugs Act and Regulations, which provide protection for pharmaceutical products. The country recognizes international patent agreements, offering a level of data exclusivity to innovators. However, the specifics of compulsory licensing provisions are not detailed in the available sources. Indian generic pharmaceutical companies should conduct thorough due diligence to understand the IP landscape and ensure compliance with local regulations when entering the Trinidad and Tobago market. (agriculture.gov.tt)

EXPORT_LOGISTICS

TransData Nexus Research · Trade policy databasesMar 2026

Supply Chain & Logistics — India to Trinidad And Tobago Pharma Shipments

Shipping routes, port infrastructure, cold chain compliance

1Shipping Routes & Transit

Major sea and air routes facilitate the transportation of pharmaceutical products from Indian ports to Trinidad and Tobago. Sea shipments typically depart from ports such as Nhava Sheva (INNSA1) and arrive at the Port of Spain (PIARC) in Trinidad and Tobago. Air shipments are often routed through Sahar Air Cargo Complex (INBOM4) to Piarco International Airport (POS) in Trinidad. Transit times vary depending on the mode of transport and specific shipping arrangements, with sea shipments generally taking longer than air shipments. Importers should coordinate with logistics providers to ensure timely and efficient delivery of pharmaceutical products.

2Port Infrastructure

Key export ports in India include Nhava Sheva Sea (INNSA1) and Sahar Air Cargo Complex (INBOM4), which handle a significant portion of pharmaceutical exports. In Trinidad and Tobago, the primary import ports are Port of Spain (PIARC), Piarco International Airport (POS), and Point Lisas (PLS). These ports are equipped to handle pharmaceutical shipments, ensuring compliance with international standards for the importation of medical products. Efficient port operations and customs procedures are essential for maintaining the integrity and timely delivery of pharmaceutical products.

3Cold Chain & Compliance

Temperature-controlled logistics are critical for maintaining the efficacy of pharmaceutical products, especially those requiring refrigeration. Indian exporters must ensure that their products are packaged and transported in compliance with Good Distribution Practice (GDP) standards, which govern the storage and transportation of pharmaceutical products. This includes using appropriate packaging materials, monitoring temperature conditions during transit, and maintaining accurate records of storage and transportation conditions. Compliance with these standards is essential for ensuring the safety and quality of pharmaceutical products upon arrival in Trinidad and Tobago.

EXPORT_OPPORTUNITY

TransData Nexus Research · DGFT port data, shipping intelligenceMar 2026

FAQ — India to Trinidad And Tobago Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Trinidad And Tobago?

India exported pharmaceuticals worth $6.4M to Trinidad And Tobago across 1,314 verified shipments.

Who are the top Indian pharmaceutical exporters to Trinidad And Tobago?

1. GLENMARK PHARMACEUTICALS LIMITED — $655.8K. 2. INDOCO REMEDIES LIMITED — $514.1K. 3. MSN LABORATORIES PRIVATE LIMITED — $447.8K. Total: 88 suppliers.

Which companies in Trinidad And Tobago import pharmaceuticals from India?

1. SUPERIOR PHARMA LIMITED — $717.9K. 2. VERNON TECHNOLOGIES LIMITED — $671.3K. 3. AP SCOTT TRINIDAD LIMITED — $461.7K. 81 buyers total.

What pharmaceutical products does India export most to Trinidad And Tobago?

1. Flamar Mx Tablet, Pack of 10x10s (each Film Coated Tablet Contains Paracetamol… ($353.4K, 5.5%); 2. Asthalin Inhaler Cfc Free 200md (salbutamol Sulphate) (1x200 Md) ($196.0K, 3.0%); 3. Alprostadil Injection USP (prostasol) 0.500 Mg/ml,1ml Vial, 1 Vial Per Box (qty… ($180.9K, 2.8%); 4. Sherpen 1000mg ($158.4K, 2.5%); 5. Norethisterone Enanthate and Estradiol Valerate Injection 50 MG + 5 Mg/ml, 1 Ml… ($154.3K, 2.4%)

Which ports handle pharmaceutical shipments from India to Trinidad And Tobago?

Export: NHAVA SHEVA SEA (INNSA1), SAHAR AIR CARGO ACC (INBOM4), HYDERABAD ACC (INHYD4), AHEMDABAD ICD (INSBI6), DELHI AIR CARGO ACC (INDEL4). Import: PORT OF SPAIN, PIARC, Port of Spain, Point Lisas, Tobago, PEORIA.

Why does Trinidad And Tobago import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $6.4M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Trinidad And Tobago?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Trinidad And Tobago pharmaceutical trade?

$4.9K per consignment across 1,314 shipments.

How many Indian pharmaceutical companies export to Trinidad And Tobago?

88 Indian companies. Largest: GLENMARK PHARMACEUTICALS LIMITED with $655.8K.

How can I find verified Indian pharmaceutical suppliers for Trinidad And Tobago?

TransData Nexus covers 88 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Trinidad And Tobago identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,314 verified shipments from 88 Indian exporters to 81 Trinidad And Tobago buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

88 Exporters

81 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Trinidad And Tobago Pharmaceutical Export